Flotetuzumab Antibody
Flotetuzumab is a CD123/CD3 bispecific DART antibody that activates T cells to eliminate CD123-expressing target cells. It has demonstrated anti-leukemic activity in preclinical models, including AML patient-derived xenografts, supporting its investigation as a potential therapeutic for acute myeloid leukemia in both in vitro and in vivo research.
Product Specifications
Target
Immunology/Inflammation related, Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction
Concentration
2.86 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15317517 1 Vial
Lentiviral human DLG3 shRNA (UAS) - Lentiviral human DLG3 shRNA (UAS) (100)
Sign In for Pricing
View Details 
LV734389 1.0 µg DNA
MT-TL2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 
VAng-Lsx1262-50gEcoli 50 µg (E. coli)
Recombinant Aeromonas Salmonicida rimP Protein
Sign In for Pricing
View Details NBP1-87552PEP 0.1 mL
Phospholipase C delta 1 Recombinant Protein Antigen
Sign In for Pricing
View Details YR0229 5 mg
In vivo Grade Recombinant HyHEL-10 Mouse IgG3 Isotype Control Antibody
Sign In for Pricing
View Details 